EUVIMEDEUVIMED entdecken
Crossref

Self‐emulsifying drug delivery system of ( R )‐ α ‐lipoic acid to improve its stability and oral absorption

Sujan Banik iD, Shimul Halder iD, Hideyuki Sato iD, Satomi Onoue iD

Biopharmaceutics & Drug Disposition · 2021-05 · 42 (5) · 226-233

DOI: 10.1002/bdd.2277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, online erschienen am 23.04.2021. Verfasst von Sujan Banik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan. Hauptthemen laut MEDLINE: Drug Delivery Systems. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study was designed to develop a self‐emulsifying drug delivery system (SEDDS) of ( R )‐ α ‐lipoic acid (RLA) to improve the physicochemical and nutraceutical properties of RLA. RLA/SEDDS was prepared using medium‐chain triglycerides, Tween 80, and polyethylene glycol 400 as oil, surfactant, and co‐surfactant, respectively. The preferable composition of SEDDS was selected according to a pseudo‐ternary phase diagram for improved emulsification properties, and its physicochemical and pharmacokinetic properties were evaluated. RLA/SEDDS showed the immediate formation of fine micelles with a mean droplet size of approximately 260 nm when introduced into aqueous media. In simulated gastric fluid, this system could significantly improve the dissolution behavior of RLA and prevent the degradation of RLA, possibly due to the encapsulation of RLA into the emulsion structure. Following the oral administration of RLA/SEDDS (10 mg RLA/kg) in rats, systemic exposure to RLA and dihydrolipoic acid (DHLA), a reduced form of RLA, increased by 7‐ and 3‐fold, respectively. The improved dissolution and gastric stability of RLA could contribute to enhancing systemic exposure to RLA and DHLA after oral administration. From these findings, RLA/SEDDS might be an efficacious dosage option for improving the oral bioavailability as well as nutraceutical properties of RLA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsAdministration, OralAnimalsAntioxidantsBiological AvailabilityDrug LiberationDrug StabilityEmulsionsGastric JuiceHydrogen-Ion ConcentrationMaleRats, Sprague-DawleySolubilityThioctic AcidRats

Stichwörter der Autor:innen

(R)-α-lipoic acidbioavailabilitydihydrolipoic acidself-emulsifying drug delivery systemstability

Substanzen

AntioxidantsEmulsionsThioctic Acid

Autor:innen und Institutionen

  • Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.

ORCID-Profile: Sujan Banik, Shimul Halder, Hideyuki Sato, Satomi Onoue

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Banik, S., Halder, S., Sato, H., & Onoue, S. (2021). Self‐emulsifying drug delivery system of ( R )‐ α ‐lipoic acid to improve its stability and oral absorption. Biopharmaceutics & Drug Disposition, 42(5), 226-233. https://doi.org/10.1002/bdd.2277

Vancouver

Banik S, Halder S, Sato H, Onoue S. Self‐emulsifying drug delivery system of ( R )‐ α ‐lipoic acid to improve its stability and oral absorption. Biopharmaceutics & Drug Disposition. 2021;42(5):226-233. doi:10.1002/bdd.2277

BibTeX
@article{Banik2021,
  author = {Banik, Sujan and Halder, Shimul and Sato, Hideyuki and Onoue, Satomi},
  title = {Self‐emulsifying drug delivery system of ( R )‐ α ‐lipoic acid to improve its stability and oral absorption},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2021},
  volume = {42},
  number = {5},
  pages = {226--233},
  doi = {10.1002/bdd.2277}
}
Kostenlos starten →